DelveInsight's 'Systemic Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of pipeline systemic lupus erythematosus therapies in various stages of clinical ...
Phase 3 trial of Biogen and UCB's dapirolizumab pegol shows significant improvement in lupus disease activity. Read more here ...
The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...
After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB ...
Then there’s physical activity: Many of the symptoms of lupus, such as joint pain, fatigue, and depression, may make patients ...
"Lupus was the perfect disease for us!" showrunner David Shore says with a laugh ahead of the 20th anniversary.
Live Science on MSN10h
'Like a reset button on a computer': Designer cells 'reboot' immune system in 3 different autoimmune diseasesA small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's ...
Lupus is a condition often shrouded in mystery. Presenting with a huge range of symptoms, it’s tricky to diagnose, tough to ...
The 1.5 million Americans estimated to have the autoimmune disease lupus already have plenty to manage—what with the pain, fatigue, hair loss, and heart problems the condition can cause.
There are multiple chapters near you. Select your preferred chapter.
High Disease Activity Linked to Lower Cervical Cancer Screening Rates in Women with SLE, Study Finds
USA: A recent study has highlighted significant barriers to cervical cancer screening among women with systemic lupus ...
ZME Science on MSN5d
Could CAR-T Therapy Be the End of Lifelong Lupus Medication? Early Results Say ‘Yes’T-cells are real life saviors. If modified properly, they can save lupus patients from the trouble of taking medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback